Terms: = Breast cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
28 results:
1. Impact of Physical Rehabilitation on Bone Biomarkers in Non-Metastatic breast cancer Women: A Systematic Review and Meta-Analysis.
de Sire A; Lippi L; Marotta N; Folli A; Calafiore D; Moalli S; Turco A; Ammendolia A; Fusco N; Invernizzi M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674436
[TBL] [Abstract] [Full Text] [Related]
2. Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics.
Chandler Y; Schechter C; Jayasekera J; Isaacs C; Kurian AW; Cadham C; Mandelblatt J
Cancer Med; 2022 Jan; 11(2):297-307. PubMed ID: 34918484
[TBL] [Abstract] [Full Text] [Related]
3. Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature.
Yagmur Y
Ann Ital Chir; 2020 Dec; 9():. PubMed ID: 33427203
[TBL] [Abstract] [Full Text] [Related]
4. breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract] [Full Text] [Related]
5. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
[TBL] [Abstract] [Full Text] [Related]
6. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract] [Full Text] [Related]
7. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
8. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.
Li X; Huang J; Luo X; Yang D; Yin X; Peng W; Bi C; Ren G; Xiang T
Int J Biol Sci; 2018; 14(12):1686-1695. PubMed ID: 30416383
[TBL] [Abstract] [Full Text] [Related]
9. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.
Dieli-Conwright CM; Courneya KS; Demark-Wahnefried W; Sami N; Lee K; Sweeney FC; Stewart C; Buchanan TA; Spicer D; Tripathy D; Bernstein L; Mortimer JE
Breast Cancer Res; 2018 Oct; 20(1):124. PubMed ID: 30340503
[TBL] [Abstract] [Full Text] [Related]
10. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract] [Full Text] [Related]
11. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study).
Barnadas A; Manso L; de la Piedra C; Meseguer C; Crespo C; Gómez P; Calvo L; Martinez P; Ruiz-Borrego M; Perelló A; Antón A; Codes M; Margelí M; Murias A; Salvador J; Seguí MÁ; de Juan A; Gavilá J; Luque M; Pérez D; Zamora P; Arizcuma A; Chacón JI; Heras L; Martin-Fernández M; Mahillo-Fernández I; Tusquets I
Bone; 2014 Nov; 68():32-40. PubMed ID: 25108081
[TBL] [Abstract] [Full Text] [Related]
12. A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.
Addison CL; Bouganim N; Hilton J; Vandermeer L; Dent S; Amir E; Hopkins S; Kuchuk I; Segal R; Song X; Gertler S; Mazzarello S; Dranitsaris G; Ooi D; Pond G; Clemons M
Breast Cancer Res Treat; 2014 Apr; 144(3):615-24. PubMed ID: 24638849
[TBL] [Abstract] [Full Text] [Related]
13. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract] [Full Text] [Related]
14. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract] [Full Text] [Related]
15. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.
Land LH; Dalton SO; Jensen MB; Ewertz M
Br J Cancer; 2012 Nov; 107(11):1901-7. PubMed ID: 23079577
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic and prognostic use of bone turnover markers.
Joerger M; Huober J
Recent Results Cancer Res; 2012; 192():197-223. PubMed ID: 22307377
[TBL] [Abstract] [Full Text] [Related]
17. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract] [Full Text] [Related]
18. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract] [Full Text] [Related]
19. Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial.
Peppone LJ; Mustian KM; Janelsins MC; Palesh OG; Rosier RN; Piazza KM; Purnell JQ; Darling TV; Morrow GR
Clin Breast Cancer; 2010 Jun; 10(3):224-9. PubMed ID: 20497921
[TBL] [Abstract] [Full Text] [Related]
20. Quality of life valuations of mammography screening.
Bonomi AE; Boudreau DM; Fishman PA; Ludman E; Mohelnitzky A; Cannon EA; Seger D
Qual Life Res; 2008 Jun; 17(5):801-14. PubMed ID: 18491217
[TBL] [Abstract] [Full Text] [Related]
[Next]
